
Annovis Bio, Inc.
ANVSNYSEHealthcareBiotechnology
As of Nov 10, 2026 close
- Market cap
- $32.80M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.62$5.50
- Volume (live)
- -
- Avg. volume (3M)
- 2.38M
Annovis Bio (ANVS) Stock Price & Financial Analysis
Annovis Bio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.81 - $0.90 |
|---|---|
| 52-Week High | $5.50 |
| 52-Week Low | $0.62 |
| Open | $0.90 |
| Volume (last close) | 1.66M |
| Average Volume (3M) | 2.38M |
| 50-Day MA | $1.14 |
|---|---|
| 200-Day MA | $1.85 |
| 1-Year Change | −58.56% |
| Market Cap | 32.80M |
|---|---|
| Shares Outstanding | 37.52M |
| Price to Book (P/B) | -7.71 |
| EV/EBITDA | -0.38 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Nov 10, 2026. Data sources and methodology
Annovis Bio at a Glance
As of the Nov 10, 2026 close, Annovis Bio (ANVS) has a market capitalization of $32.80M.
As of its latest reported balance sheet, it holds $18.73M in cash and securities against $0.00 of debt, a net cash position of $18.73M.
Annovis Bio does not currently pay a dividend.
The share price is down 58.6% over the past year. At $0.87 (the Nov 10, 2026 close) it sits near the bottom of its 52-week range of $0.62 to $5.50, below its 200-day moving average of $1.84.
Frequently Asked Questions About Annovis Bio
What is the current stock price for ANVS?
As of the Nov 10, 2026 close, ANVS stock trades at $0.87. The 52-week range is $0.62–$5.50, with a day range of $0.81–$0.90.
What is the P/E ratio for ANVS?
Annovis Bio has no trailing P/E ratio because it reported a net loss over the last twelve months.
Does ANVS pay dividends?
Annovis Bio does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What is the market cap of ANVS?
As of the Nov 10, 2026 close, Annovis Bio's market capitalization is $32.8M, classifying it as a micro-cap company. Annovis Bio operates in the Healthcare sector within the Biotechnology industry.